Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business Practice

Business & Regulation Profession

Is Pharma’s Reputation in Paradise or Purgatory?

| Angus Stewart

We get the lowdown on the Reputation Index, which was recently published by the Association of the British Pharmaceutical Industry.

Business & Regulation Business Practice

Stepping Away from the Flame

| Maryam Mahdi

The pharma industry is one of the biggest targets for cybercrime. How can companies avoid succumbing to attack?

Business & Regulation Profession

Stay True to Yourself!

| Maryam Mahdi

Sitting Down With… Evelina Vågesjö, Chief Executive Officer at Ilya Pharma, Sweden.

Business & Regulation Clinical Trials

Remembering Henrietta

| Maryam Mahdi

On the 70th anniversary of death Henrietta Lacks, we examine her contributions to science and what they mean for modern research.

Business & Regulation Business Practice

Cast Out the Oracles

| Angus Stewart

Mike Rea of IDEA Pharma shares his thoughts on what players pharma in positioning are getting right – and wrong.

Manufacture Contract Manufacturing Services

Tackling the High-Potency Trend

| Sponsored by PCI

Defining the best strategies for working with highly potent drug substances.

Discovery & Development Drug Discovery

What a Difference a Year Makes

| Maryam Mahdi

How a drug approval changed the lives of patients living with rare disease.

Business & Regulation Business Practice

Seriously Y'all Stop It

| Stephanie Sutton

Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.

Discovery & Development Drug Discovery

Staying on the Track to Eradication

| Rosanne Rotondo

A diverse range of malaria treatments will make all the difference in the prevention of resistance.

Discovery & Development Clinical Trials

Malaysia in the Middle: Tackling Hep C in an Unfair World

| Angus Stewart

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.


Latest White Papers

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register